Stereoselective inhibition of CYP2C19 and CYP3A4 by fluoxetine and its metabolite: implications for risk assessment of multiple time-dependent inhibitor systems (Q37325598)
Jump to navigation
Jump to search
scientific article published on 19 June 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Stereoselective inhibition of CYP2C19 and CYP3A4 by fluoxetine and its metabolite: implications for risk assessment of multiple time-dependent inhibitor systems |
scientific article published on 19 June 2013 |
Statements
1 reference
Stereoselective inhibition of CYP2C19 and CYP3A4 by fluoxetine and its metabolite: implications for risk assessment of multiple time-dependent inhibitor systems (English)
1 reference
Justin D Lutz
1 reference
Brooke M VandenBrink
1 reference
Katipudi N Babu
1 reference
Wendel L Nelson
1 reference
Kent L Kunze
1 reference
Nina Isoherranen
1 reference
19 June 2013
1 reference
1 reference
2056-2065
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference